Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Correction to: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment.
Journal: European journal of drug metabolism and pharmacokinetics
Published: March 08, 2022
A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment.
Journal: European journal of drug metabolism and pharmacokinetics
Published: December 12, 2021
Showing 1-2 of 2
Last Updated: 09/26/2026